Guidelines versus clinical practice - Which therapy and which device?

Respiratory Medicine

Volumn 98, Issue SUPPL. 2, 2004, Pages

  Virchow, J Christian ^a  

^a ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

Author keywords

2 agonists; Asthma; Corticosteroids; Dry powder inhaler DPI; Inhalation; Therapy

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CHLOROFLUOROCARBON; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; LONG ACTING DRUG; SALBUTAMOL; SHORT ACTING DRUG; THEOPHYLLINE;

ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRY POWDER; EQUIPMENT DESIGN; FEEDBACK SYSTEM; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION TEST; METERED DOSE INHALER; PEAK EXPIRATORY FLOW; POSTMARKETING SURVEILLANCE; POWDER INHALER; PRACTICE GUIDELINE; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; SUSTAINED RELEASE FORMULATION;

ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHODILATOR AGENTS; BUDESONIDE; FORCED EXPIRATORY VOLUME; HUMANS; METERED DOSE INHALERS; PRACTICE GUIDELINES; PRODUCT SURVEILLANCE, POSTMARKETING; PROFESSIONAL PRACTICE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RANDOMIZED CONTROLLED TRIALS; VITAL CAPACITY;

EID: 11144325053     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2004.07.012     Document Type: Article

References (29)

1. Global strategy for asthma management and prevention. NHLBI/WHO workshop report. NIH publication No. 95-3659, National Institute of Health, Bethesda, MD, 2002.
2. J. Toogood J. Baskerville B. Jennings N. LeFcoe S. Johansson Bioequivalent doses of budesonide and prednisone in moderate and severe asthma J Allergy Clin Immunol 84 1989 688-700
3. Montreal protocol on substances that deplete the ozone layer. Treaty Doc. No. 10, 100th Congress, ILM 1987.
4. B. O'Connor The ideal inhaler design characteristics to improve outcomes Respir Med 98 Suppl A 2004 S10-S16
5. L. Agertoft S. Pedersen K. Nikander Drug delivery from the Turbuhaler and Nebuhaler pressurised metered dose inhaler to various age groups of children with asthma J Aerosol Med 12 1999 161-169
6. B. Lipworth D. Clark Lung delivery of salbutamol given by breath activated pressurised aerosol and dry powder inhaler devices Pulm Pharmacol Ther 10 1997 211-214
7. R. Wettengel D. Berdel D. Hofmann et al. Asthma therapy in children and adults Med Klink 93 1998 639-650
8. Bateman E, et al. GOAL study. 4th triennial World Asthma Meeting. Thailand, February 16-19, 2004. p. 131.
9. N. Vanacker E. Palmans R. Pauwels J. Kips Dose-related effect of inhaled fluticasone on allergen-induced airway changes in rats Eur Respir J 20 2002 873-879
10. Guidelines for the management of asthma in adults. 2-acute severe asthma. Statement by the British Thoracic Society, Research Unit of the Royal College of Physicians of London, King's Fund Centre, National Asthma Campaign. Br Med J 1990;301:797-800.
11. Guidelines for the management of asthma in adults.1-chronic persistent asthma. Statement by the British Thoracic Society, Research Unit of the Royal College of Physicians of London, King's Fund Centre, National Asthma Campaign. Br Med J 1990;301:651-653.
12. S. Newman G. Pitcairn P. Hirst et al. Scintigraphic comparison of budesonide deposition from two dry powder inhalers Eur Respir J 16 2000 178-183
13. S. Newman J. Brown K. Steed S. Reader H. Kladders Lung deposition of fenoterol and flunisolide delivered using a novel device for inhaled medicines comparison of RESPIMAT with conventional metered-dose inhalers with and without spacer devices Chest 113 1998 957-963
14. H. Pickering G. Pitcairn P. Hirst et al. Regional lung deposition of technetium 99 m-labeled formulation of mometasone furoate administered by hydrofluoroalkane 227 metered dose inhaler Clin Ther 22 2000 1483-1493
15. G. Crompton Problems patients have using pressurized aerosol inhalers Eur Respir Dis 119 1982 101-104
16. V. Giraud N. Roche Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability Eur Respir J 19 2002 246-251
17. P. Hirst G. Pitcairn J. Richards et al. Deposition and pharmacokinetics of an HFA formulation of triamcinolone acetonide delivered by pressurized metered dose inhaler J Aerosol Med 14 2001 155-165
18. E. Berg J. Madsen H. Bisgaard In vitro performance of three combinations of spacers and pressurized metered dose inhalers for treatment in children Eur Respir J 12 1998 472-476
19. P. Ernst Inhaled drug delivery a practical guide to prescribing inhaler devices Can Respir J 5 1998 180-183
20. A. Kamps P. Brand R. Roorda Determinants of correct inhalation technique in children attending a hospital-based asthma clinic Acta Paediatr 91 2002 159-163
21. R. Ruffin D. Campbell M. Chia Post-inhalation bronchoconstriction by beclomethasone dipropionate a comparison of two different CFC propellant formulations in asthmatics Respirology 5 2000 125-131
22. J. van der Palen J. Klein C. van Herwaarden G. Zielhuis E. Seydel Multiple inhalers confuse asthma patients Eur Respir J 14 1999 1034-1037
23. I. Cerveri F. Locatelli M. Zoia et al. International variations in asthma treatment compliance the results of the European Community Respiratory Health Survey (ECRHS) Eur Respir J 14 1999 288-294
24. D. Kohler The Novolizer overcoming inherent problems of other dry powder inhalers Respir Med 98 Suppl A 2004 S17-S21
25. B. Fyrnys N. Stang E. Wolf-Heuss Stability and performance characteristics of a budesonide powder for inhalation with a novel dry powder inhaler device Curr Opin Pulm Med 7 Suppl 1 2001 S7-S11
26. M. Everard S. Devadason P. Souef Flow early in the inspiratory manoeuvre affects the aerosol particle size distribution from a Turbuhaler Respir Med 91 1997 624-628
27. G. Kunkel A. Chuchalin Therapeutic equivalence of the Sofotec Novolizer to established standard devices in COPD and asthma Curr Opin Pulm Med 7 Suppl 1 2001 S15-S17
28. A. Chuchalin H. Kremer P. Metzenauer E. O'Keefe R. Hermann Clinical equivalence trial on budesonide delivered either by the Novolizer multidose dry powder inhaler or the Turbuhaler in asthmatic patients Respiration 69 2002 502-508
29. M. Möller D. Fritsche D. Rivera H. Libertus Improvement of asthma therapy by a novel budesonide multidose dry powder inhaler Drug Res 53 2003 562-567